Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2020

Open Access 01-12-2020 | SARS-CoV-2 | Research article

Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach

Authors: Derek Hazard, Klaus Kaier, Maja von Cube, Marlon Grodd, Lars Bugiera, Jerome Lambert, Martin Wolkewitz

Published in: BMC Medical Research Methodology | Issue 1/2020

Login to get access

Abstract

Background

The clinical progress of patients hospitalized due to COVID-19 is often associated with severe pneumonia which may require intensive care, invasive ventilation, or extracorporeal membrane oxygenation (ECMO). The length of intensive care and the duration of these supportive therapies are clinically relevant outcomes. From the statistical perspective, these quantities are challenging to estimate due to episodes being time-dependent and potentially multiple, as well as being determined by the competing, terminal events of discharge alive and death.

Methods

We used multistate models to study COVID-19 patients’ time-dependent progress and provide a statistical framework to estimate hazard rates and transition probabilities. These estimates can then be used to quantify average sojourn times of clinically important states such as intensive care and invasive ventilation. We have made two real data sets of COVID-19 patients (n = 24* and n = 53**) and the corresponding statistical code publically available.

Results

The expected lengths of intensive care unit (ICU) stay at day 28 for the two cohorts were 15.05* and 19.62** days, while expected durations of mechanical ventilation were 7.97* and 9.85** days. Predicted mortality stood at 51%* and 15%**. Patients mechanically ventilated at the start of the example studies had a longer expected duration of ventilation (12.25*, 14.57** days) compared to patients non-ventilated (4.34*, 1.41** days) after 28 days. Furthermore, initially ventilated patients had a higher risk of death (54%* and 20%** vs. 48%* and 6%**) after 4 weeks. These results are further illustrated in stacked probability plots for the two groups from time zero, as well as for the entire cohort which depicts the predicted proportions of the patients in each state over follow-up.

Conclusions

The multistate approach gives important insights into the progress of COVID-19 patients in terms of ventilation duration, length of ICU stay, and mortality. In addition to avoiding frequent pitfalls in survival analysis, the methodology enables active cases to be analyzed by allowing for censoring. The stacked probability plots provide extensive information in a concise manner that can be easily conveyed to decision makers regarding healthcare capacities. Furthermore, clear comparisons can be made among different baseline characteristics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M. Application of multistate models in hospital epidemiology: advances and challenges. Biom J. 2011;53(2):332–50.CrossRef Beyersmann J, Wolkewitz M, Allignol A, Grambauer N, Schumacher M. Application of multistate models in hospital epidemiology: advances and challenges. Biom J. 2011;53(2):332–50.CrossRef
2.
go back to reference Wolkewitz M, von Cube M, Schumacher M. Multistate modeling to analyze nosocomial infection data: an introduction and demonstration. Infect Control Amp Hosp Epidemiol. 2017;38(8):953–9.CrossRef Wolkewitz M, von Cube M, Schumacher M. Multistate modeling to analyze nosocomial infection data: an introduction and demonstration. Infect Control Amp Hosp Epidemiol. 2017;38(8):953–9.CrossRef
3.
go back to reference van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol. 2004;57(7):672–82.CrossRef van Walraven C, Davis D, Forster AJ, Wells GA. Time-dependent bias was common in survival analyses published in leading clinical journals. J Clin Epidemiol. 2004;57(7):672–82.CrossRef
4.
go back to reference Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol. 2008;61(12):1216–21.CrossRef Beyersmann J, Gastmeier P, Wolkewitz M, Schumacher M. An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol. 2008;61(12):1216–21.CrossRef
5.
go back to reference Wolkewitz M, Cooper BS, Bonten MJM, Barnett AG, Schumacher M. Interpreting and comparing risks in the presence of competing events. BMJ. 2014;349:g5060.CrossRef Wolkewitz M, Cooper BS, Bonten MJM, Barnett AG, Schumacher M. Interpreting and comparing risks in the presence of competing events. BMJ. 2014;349:g5060.CrossRef
6.
go back to reference Wolkewitz M, Schumacher M. Survival biases lead to flawed conclusions in observational treatment studies of influenza patients. J Clin Epidemiol. 2017;84:121–9.CrossRef Wolkewitz M, Schumacher M. Survival biases lead to flawed conclusions in observational treatment studies of influenza patients. J Clin Epidemiol. 2017;84:121–9.CrossRef
7.
go back to reference Wolkewitz M, Schumacher M. Neuraminidase inhibitors and hospital mortality in British patients with H1N1 influenza a: a re-analysis of observational data. PLoS One. 2016;11(9):e0160430.CrossRef Wolkewitz M, Schumacher M. Neuraminidase inhibitors and hospital mortality in British patients with H1N1 influenza a: a re-analysis of observational data. PLoS One. 2016;11(9):e0160430.CrossRef
8.
go back to reference Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. New England Journal of Medicine. 2020 ;382(21):2012–22. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. New England Journal of Medicine. 2020 ;382(21):2012–22.
9.
go back to reference Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. New England Journal of Medicine. 2020;382(24):2327–36. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. New England Journal of Medicine. 2020;382(24):2327–36.
10.
go back to reference Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11(2):91–115.CrossRef Andersen PK, Keiding N. Multi-state models for event history analysis. Stat Methods Med Res. 2002;11(2):91–115.CrossRef
11.
go back to reference Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. New York: Springer Science & Business Media; 2012. p. 779. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. New York: Springer Science & Business Media; 2012. p. 779.
12.
go back to reference Beyersmann J, Putter H. A note on computing average state occupation times. Demogr Res. 2014;30:1681–96.CrossRef Beyersmann J, Putter H. A note on computing average state occupation times. Demogr Res. 2014;30:1681–96.CrossRef
14.
go back to reference Beyersmann J, Allignol A, Schumacher M. Competing Risks and Multistate Models with R. New York: Springer Science & Business Media; 2011. p. 249. Beyersmann J, Allignol A, Schumacher M. Competing Risks and Multistate Models with R. New York: Springer Science & Business Media; 2011. p. 249.
15.
go back to reference Compassionate Use of Remdesivir in Covid-19. N Engl J Med. 2020;382(25):e101. Compassionate Use of Remdesivir in Covid-19. N Engl J Med. 2020;382(25):e101.
16.
go back to reference Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis. 2015;9(7):e0003846.CrossRef Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, et al. Potential biases in estimating absolute and relative case-fatality risks during outbreaks. PLoS Negl Trop Dis. 2015;9(7):e0003846.CrossRef
17.
go back to reference Cube M von, Grodd M, Wolkewitz M, Hazard D, Lambert J. Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information - an essential step to facilitate decision making. medRxiv. 2020;2020.03.31.20049007. Cube M von, Grodd M, Wolkewitz M, Hazard D, Lambert J. Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information - an essential step to facilitate decision making. medRxiv. 2020;2020.03.31.20049007.
Metadata
Title
Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach
Authors
Derek Hazard
Klaus Kaier
Maja von Cube
Marlon Grodd
Lars Bugiera
Jerome Lambert
Martin Wolkewitz
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2020
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-020-01082-z

Other articles of this Issue 1/2020

BMC Medical Research Methodology 1/2020 Go to the issue